Ben Around

Immunogen and Seattle Genetics: Verging on an Inflection Point

Very interesting article.
I have been in and out of imgn for years and watch it track from 3-6, usually with some justification of the price variations from external influences.
This latest drop on tuesday (June 3) completely baffles me. I look at it as a buy in again opportunity since I can't see any other reason other than small investor interest.

Any in comments on Tuesday's action?

Why is Wall Street Ignoring ImmunoGen?

I agree, but I also am a long time long waiting for vindication of my decision to buy.

Hope we will get noticed.